Position in LNTH
as of Mar 31, 2026
· filed Jun 15, 2026
Position Value
$100,728,800
+$26,059,700 QoQ
Shares Held
1,328,000
+18.4% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Carmignac Gestion holds $125,232,440 across 2 Drug Manufacturers - Specialty & Generic names. LNTH ranks #1 (80.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
This page
|
1,328,000 | $100,728,800 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
186,000 | $24,503,640 |
All Filings in LNTH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,728,800 | 1,328,000 | Shares | Sole | 2026-06-15 | |
| 2025-12-31 | $74,669,100 | 1,122,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $41,412,007 | 807,409 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $24,312,420 | 297,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $18,592,800 | 190,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,817,342 | 232,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,156,475 | 138,100 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,407,142 | 79,800 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||